In the BioHarmony Drug Report Database
Tesamorelin
Egrifta Sv (tesamorelin) is a protein pharmaceutical. It is marketed in the US. The pharmaceutical is active against growth hormone-releasing hormone receptor.
Trade Name
|
Egrifta Sv |
|---|---|
Common Name
|
tesamorelin |
ChEMBL ID
|
CHEMBL1237026 |
Indication
|
hiv-associated lipodystrophy syndrome |
Drug Class
|
Prehormones or hormone-release stimulating peptides: growth hormone-release stimulating peptides |
Image (chem structure or protein)
